One-Time treatment aims to free patients from lifelong blood transfusions
NCT ID NCT06308159
Summary
This trial is testing a one-time gene therapy for people with severe beta-thalassemia who need regular blood transfusions to survive. Doctors take a patient's own blood stem cells, add a corrected gene in the lab, and then return them to the patient. The goal is to see if this treatment is safe and can help the body make enough healthy hemoglobin on its own, potentially ending the need for transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BETA-THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
RECRUITINGKunming, Yunnan, 650100, China
Contact Email: •••••@•••••
-
Kunming Hope of Health Hospital
RECRUITINGKunming, Yunnan, 650200, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.